<DOC>
	<DOCNO>NCT01661803</DOCNO>
	<brief_summary>The investigator summarize intrathecal clonidine potentiate bupivacaine thereby bring good quality long duration analgesia , good sedation well postoperative outcome minimal side effect .</brief_summary>
	<brief_title>Intrathecal Bupivacaine Versus Bupivacaine Clonidine Paediatrics Age Group : A Comparative Evaluation</brief_title>
	<detailed_description>In Randomized control , double blind study involve 30 subject two group ; investigator compare safety , efficacy quality use intrathecal hyperbaric bupivacaine 0.5 % hyperbaric bupivacaine 0.5 % clonidine 1µg/kg paediatric patient undergo surgery T8 dermatome . American Society Anesthesiologists ( ASA ) Grade I patient age 3-10 year schedule surgery T8 dermatome two hrs duration . The patient randomly allocate - Group A-who receive 0.5 % hyperbaric Bupivacaine 0.4mg/kg 5 to15 kg 0.3 mg/kg 15 kg intrathecally . Group B-who receive 0.5 % hyperbaric Bupivacaine 0.4mg/kg 5 to15 kg 0.3 mg/kg 15 kg 1µg/kg preservative free clonidine intrathecally . The patient study across group vary much respect age , weight sex distribution .</detailed_description>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>1 . ASA grade1 physical status . 2. weight 535kg 3. age3 10 yr 1. patient know sensitivity drug use . 2. gross spinal deformity 3. patient regional anesthesia contraindicate . 4. patient peripheral neuropathy . 5. patient hemodynamic instability .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>bupivacaine</keyword>
	<keyword>clonidine</keyword>
	<keyword>pediatric spinal</keyword>
	<keyword>efficacy</keyword>
	<keyword>duration</keyword>
	<keyword>quality</keyword>
	<keyword>side effect</keyword>
	<keyword>intrathecal bupivacaine alone</keyword>
	<keyword>bupivacaine plus clonidine</keyword>
</DOC>